Skip to table dataSkip to menuSkip to searchHotkeys reference

EEMB

 

Estonian Electronic Microbial dataBase

Eesti Elektrooniline Mikroobide andmeBaas

 f123552me-3138438574957507417
Publications

PATENTS

 

M. Mikelsaar, M. Zilmer, T. Kullisaar, H. Annuk, E. Songisepp. International Patent application: no. PCT/EE02/00006 28.06.2002. The strain of microorganism Lactobacillus fermentum ME-3 as novel antimicrobial and antioxidant probiotic. Avaldatud 09.01.03. numbri WO 030022131 all (http://worldwide.espacenet.com/).

 

M. Mikelsaar, M. Zilmer, T. Kullisaar, H. Annuk, E. Songisepp. P200100356 29.06.2001: Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui uudne antimikroobne ja antioksüdantne probiootikum.

 

Mikelsaar, M., Zilmer, M., Kullisaar, M., Annuk, H., Songisepp, E. Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum. Patendi taotleja Tartu Ülikool. EV Patendiamet, patent nr. 12/P200100356, 19.12.2005

 

Songisepp, E.; Mikelsaar, M.; Rätsep, M.; Zilmer, M.; Zilmer , K.; Üksti, J.; Kõljalg, S. Isoleeritud mikroorganismi tüvi Lactobacillus plantarum Tensia DSM 21380 kui antimikroobne ja antihüpertensiivne probiotik, toiduprodukt ja Komposition mis sisaldab vastavat mikroorganismi ja selle mikroorganismi kasutus antihüpertensiivse ravimi valmistamiseks ja meetod patogeenide ja mitte-starter laktobatsillide allasurumiseks toiduproduktis. Espacenet 2009, WO2009138091. Strain and patent owner: Bio-Competence Centre of Healthy Dairy Products.

 

Mikelsaar, M.; Songisepp, E.; Smidt, I.; Stsepetova J., Hütt, P.; Zilmer, M.; Truusalu, K.; Kilk, K. PCT/EE2009/000006 Isolated Lactobacillus plantarum strain Inducia DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it. Espacenet 2009, WO2009138092. Strain and patent owner: Bio-Competence Centre of Healthy Dairy Products.2015

 

 

Ph.D. DISSERTATIONS

 

Ausmees, K. Reproductive function in middle-aged males: Associations with prostate, lifestyle and coulpe infertility status. Disserationes Medicinae  Universitatis Tartuensis. Tartu, 2014.

 

Truusalu K. Probiotic lactobacilli in experimental persistent Salmonella infection. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2013.

 

Hütt P. Functional properties, persistence, safety and efficacy of potential probiotic lactobacilli. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2012.

 

Parm Ü. Early mucosal colonisation and its role in prediction of invasive infection in neonates at risk of early onset sepsis. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2012

 

Štšepetova J. The characterisation of intestinal lactic acid bacteria using bacteriological, biochemical and molecular approaches. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2011.

 

Metsvaht T. Optimal antibacterial therapy of neonates at risk of early onset sepsis. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2010.

 

Türk S. Etiopathogenetic aspects of chronic prostatitis: role of mycoplasmas, coryneform bacteria and oxidative stress. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2009.

 

Korrovits P. Asymptomatic inflammatory prostatitis: prevalence, etiological factors, diagnostic tools. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2008.

 

Andreson H. Diversity of Helicobacter pylori genotypes in Estonian patients with chronic inflammatory gastric disease. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2006.

 

Kõll P. Oral lactoflora in chronic periodontitis and periodontal health. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2006.

 

Kasenõmm P. Indicators for tonsillectomy in adults with recurrent tonsillitis clinical, microbiological and pathomorphological investigations. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2005.

 

Songisepp E. Evaluation of technological and functional properties of the new probiotic Lactobacillus fermentum ME-3. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2005

 

Lõivukene, K. Helicobacter pylori in gastric microbial ecology and its antimicrobial susceptibility pattern. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2003.

 

Krüüner, A. Drug-resistant Mycobacterium tuberculosis in Estonia. Karolinska Institutet, Stockholm, Sweden, 2003.

 

Annuk, H. Selection of medicinal plants and intestinal lactobacilli as antimicrobial components for functional foods. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2002.

 

Krüüner, A. Mycobacterium tuberculosis spread and drug resistance in Estonia. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 2001.

 

Kõljalg S. Acinetobacter - an important nosocomial pathogen. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 1999.

 

Sepp E. Formation of intestinal microbial ecosystem in children. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 1998.

 

Naaber P. Clostridium difficile infection and intestinal microbial ecology. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 1997.

 

Mändar R. Vaginal microflora during pregnancy and its transmission to newborn. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 1996.

 

Karki T. Quantitative composition of the human lactoflora and method for its examination. Dissertationes Medicinae Universitatis Tartuensis. Tartu, 1996.

 

 

MSc DISSERTATIONS

 

Kristiine Pai. Balti regioonis kliinilistest materjalidest isoleeritud Escherichia coli tüvede laiendatud toimega beeta-laktamaaside produktsiooni fenotüübiline ja genotüübiline iseloomustus. Tartu, 2014. Juhendajad: Epp Sepp, Siiri Kõljalg, Andres Mäe.

 

Natalja Šebunova. Erinevate vanuserühmade tervete inimeste soolestiku mikroobikoosluse molekulaarne kvantitatiivne analüüs. Tartu, 2014. Juhendajad: Jelena Štšepetova, Eeva Heinaru.

 

Jana Lillo. Inimese kliinilistest materjalidest ja normaalsest soole mikrofloorast isoleeritud Escherichia coli tüvede virulentsusfaktorid. Tartu, 2013. Juhendajad: Epp Sepp, Siiri Kõljalg, Riho Teras.

 

Ave Ahelik. Oksüdatiivne stress viljatutel paaridel. Tartu, 2013. Juhendajad: Reet Mändar, Tiiu Kullisaar, Sulev Ingerpuu.

 

Eleri Lapp. Kehavälise viljastamise ebaedu põhjused: suguteede põletikud, tervislik seisund ja tervisekäitumine mõlemal partneril. Tartu, 2013. Juhendaja: Reet Mändar.

 

Riinu Kiiker. Ureaplasmad ja laktobatsillid viljatute paaride suguteede mikrobiootas ning seksuaalvahekorra mõju tupe mikroobikooslusele. Tartu, 2013. Juhendajad: Reet Mändar, Jaanis Juhanson.

 

Helen Oopkaup. Piimhappebakterite poolt toodetud bio- ja polüamiinide geeniklastrite biosünteesi molekulaarne analüüs. Tartu, 2013. Juhendajad: Jelena Štšepetova, Eeva Heinaru, Epp Songisepp.

 

Jana Lillo. Inimese kliinilistest materjalidest ja normaalsest soole mikrofloorast isoleeritud Escherichia coli tüvede virulentsusfaktorid. Tartu, 2013. Juhendajad: Epp Sepp, Siiri Kõljalg, Riho Teras.

 

Ave Ahelik. Oksüdatiivne stress viljatutel paaridel. Tartu, 2013. Juhendajad: Reet Mändar, Tiiu Kullisaar, Sulev Ingerpuu.

 

Eleri Lapp. Kehavälise viljastamise ebaedu põhjused: suguteede põletikud, tervislik seisund ja tervisekäitumine mõlemal partneril. Tartu, 2013. Juhendaja: Reet Mändar.

 

Riinu Kiiker. Ureaplasmad ja laktobatsillid viljatute paaride suguteede mikrobiootas ning seksuaalvahekorra mõju tupe mikroobikooslusele. Tartu, 2013. Juhendajad: Reet Mändar, Jaanis Juhanson.

 

Helen Oopkaup. Piimhappebakterite poolt toodetud bio- ja polüamiinide geeniklastrite biosünteesi molekulaarne analüüs. Tartu, 2013. Juhendajad: Jelena Štšepetova, Eeva Heinaru, Epp Songisepp.

 

Borovkova N. Influence of sexual intercourse on vaginal microbiota in infertile couples. Dissertation of Master's Degree. Tartu Ülikool, 2010.

 

Rätsep M. Antimicrobial properties of Lactobacillus plantarum strains and their application possibilities in dairy industry. Dissertation of Master's Degree. Tartu Ülikool, 2009.

 

Drell, T. Development of intestinal microbiota in pre- and fullterm infants. Dissertation of Master's Degree. Tartu Ülikool, 2009.

 

Songisepp, Epp. Lactobacillar starters with special biomarkers: biotechnological management and influence on the lactoflora of products and host. Dissertation of Master's Degree. Tartu, 2002.

 

Andreson, Helena. Molecular virulence markers of Helicobacter pylori strains spread in South Estonia. Dissertation of Master's Degree. Tartu, 2002.

 

Lõivukene K. Antibiotic susceptibility of Helicobacter pylori strains and it's relations with vacA and cagA genotype in patients with gastritis and peptic ulcer. Dissertation of Master's Degree. Tartu, 2000.

 

Smidt I. In vitro and in vivo interaction of intestinal indigenous lactobacilli and opportunistic pathogens Clostridium difficile and Escherichia coli. Dissertation of Master's Degree. Tartu, 1999

 

 

MONOGRAPHIES

 

Naaber, P., Mikelsaar, M. Interactions between lactobacilli and antibiotic-associated diarrhea. In: Advances in Applied Microbiology. Eds. A.I. Laskin, J.W. Bennett, G.M. Gadd. Volume 54. Elsevier Inc., 2004, 231-260.

 

Mikelsaar, M., Mändar, R., Sepp, E., Annuk, H. Human lactic acid microflora and its role in the welfare of the host. In: Lactic Acid Bacteria. Eds. S. Salminen, A. von Wright, A. Ouwehand. Marcel Dekker Inc., 2004, 453-506.

 

Mikelsaar, M., Mändar, R., Sepp, E.. Lactic acid microflora in the human microbial ecosystem and its development. In: Lactic Acid Bacteria, Marcel Dekker, Inc., New York, USA, 1998, 279-342. ISBN 0-8247-0133-X

 

Türk S, Kullisaar T, Korrovits P, Ausmees K, Punab M, Mändar R. (2011). Some etiopathogenetic aspects of chronic prostatitis: mycoplasmas, coryneform bacteria and oxidative stress. Charleston, CreateSpace, 98 p.

 

Korrovits P, Punab M, Mändar R. (2011). Asymptomatic inflammatory prostatitis. Charleston, CreateSpace, 68 p.

 

 

PAPERS IN INTERNATIONAL JOURNALS

2016

 

Vaikjärv, Risto; Kasenõmm, Priit; Jaanimäe, Liis; Kivisild, Ave; Rööp, Tiiu; Sepp, Epp; Mändar, Reet. (2016). Microbiology of peritonsillar abscess in the South Estonian population. Microbial Ecology in Health and Disease, 27, 27787.

 

Mändar, Karsten; Sõber, Tiina; Kõljalg, Siiri; Rööp, Tiiu; Mändar, Reet; Sepp, Epp. (2016). Microbiological contamination of the euro currency in Estonia. Infectious Diseases, 48 (10), 772?774, 10.1080/23744235.2016.1201725.

 

2015

 

Mikelsaar, Marika; Sepp, Epp; Štšepetova, Jelena; Hütt, Pirje; Zilmer, Kersti; Kullisaar, Tiiu; Zilamer, Mihkel. (2015). Regulation of plasma lipid profile by lactobacillus fermentum (probiotic strain ME-3 DSM14241) in a randomised controlled trial of clinically healthy adults. BMC Nutrition, 1 (27), 1?13, s40795-015-0020-z.

 

Smidt, Imbi; Kiiker, Riinu; Oopkaup, Helen; Lapp, Eleri; Rööp, Tiiu; Truusalu, Kai; Štšepetova, Jelena; Truu, Jaak; Mändar, Reet. (2015). Comparison of detection methods for vaginal lactobacilli . Beneficial Microbes, 2015 Apr 13:1-5

 

Mändar, Reet; Punab, Margus; Borovkova, Natalja; Lapp, Eleri; Kiiker, Riinu; Korrovits, Paul; Metspalu, Andres; Krjutškov, Kaarel; Nõlvak, Hiie; Preem, Jens-Konrad; Oopkaup, Kristjan; Salumets, Andres; Truu, Jaak. (2015). Complementary seminovaginal microbiome in couples. Research in Microbiology, 166(5), 440-7

 

Korrovits, Paul; Lapp, Eleri; Mändar, Reet. (2015). Couple-related factors of ART outcome. Clinical & Experimental Obstetrics & Gynecology, 166(5), 440-7.

 

Drell, Tiina; Larionova, Anneli; Voor, Tiia; Simm, Jaak; Julge, Kaja; Heilman, Kaire; Tillmann, Vallo; Štšepetova, Jelena; Sepp, Epp (2015). Differences in Gut Microbiota Between Atopic and Healthy Children. Current Microbiology, 71(2), 177 - 183.

 

Parm, Ülle; Metsvaht, Tuuli; Ilmoja, Mari-Liis; Lutsar, Irja (2015). Gut colonization by aerobic microorganisms is associated with route and type of nutrition in premature neonates. Nutrition Research, 35(6), 496 - 503.

 

Hütt, Pirje; Songisepp, Epp; Rätsep, Merle; Mahlapuu, Riina; Kilk, Kilk; Mikelsaar, Marika. (2015). Impact of probiotic L. plantarum TENSIA in different dairy products on anthropometric and blood biochemical indices of healthy adults. Beneficial Microbes, 2015; 6(3):233-43. 

 

Putrinš, Marta; Kogermann, Karin; Lukk, Eliisa; Lippus, Markus; Varik, Vallo; Tenson, Tanel (2015). Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement . Infection and immunity, 83(3), 1056 - 1067. 

 

 

2014

 

Rätsep, Merle; Naaber, Paul; Kõljalg, Siiri; Shkut, Elena; Sepp, Epp (2014). Effect of Lactobacillus Strain on Clinical Isoletes of Clostridium difficile in vitro. Journal of Probiotics and Health, 2, 1?5, 2329-8901.1000119

 

Kõljalg S, Telling K, Huik K, Murruste M, Saarevet V, Pauskar M, Lutsar I. First report of Wohlfahrtiimonas chitiniclastica from soft tissue and bone infection at an unusually high northern latitude. Folia Microbiol (Praha). 2014 Oct 11. [Epub ahead of print]

 

Drell T, Lutsar I, Stšepetova J, Parm U, Metsvaht T, Ilmoja ML, Simm J, Sepp E. The development of gut microbiota in critically ill extremely low birth weight infants assessed with 16S rRNA gene based sequencing. Gut Microbes. 2014 May-Jun;5(3):304-12.

 

Kõljalg, Siiri; Truusalu, Kai; Štšepetova, Jelena; Pai, Kristiine; Vainumäe, Inga; Sepp, Epp; Mikelsaar, Marika (2014). The Escherihia coli phylogenetic group B2 with integrons prevails in childhood recurrent urinary tract infections. APMIS, 122(5), 452 - 458.

 

Lillo J, Pai K, Balode A, Makarova M, Huik K, Kõljalg S, Ivanova M, Kaftyreva L, Miciuleviciene J, Naaber P, Parv K, Pavelkovich A, Rööp T, Toompere K, Suzhaeva L, Sepp E. Differences in Extended-Spectrum Beta-Lactamase Producing Escherichia coli Virulence Factor Genes in the Baltic Sea Region. Biomed Res Int. 2014;2014:427254.

 

Lutsar I, Chazallon C, Carducci FI, Trafojer U, Abdelkader B, de Cabre VM, Esposito S, Giaquinto C, Heath PT, Ilmoja ML, Katragkou A, Lascoux C, Metsvaht T, Mitsiakos G, Netzer E, Pugni L, Roilides E, Saidi Y, Sarafidis K, Sharland M, Usonis V, Aboulker JP; NeoMero Consortium. Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr. 2014 Aug;173(8):997-1004.

 

Lutsar I, Telling K, Metsvaht T. Treatment option for sepsis in children in the era of antibiotic resistance. Expert Rev Anti Infect Ther. 2014 Oct;12(10):1237-52.

 

Mitt, P.; Metsvaht, T.; Adamson, V.; Telling, K..; Naaber, P.; Lutsar, I.; Maimets , M. (2014). Five-year prospective surveillance of nosocomial bloodstream infections in an Estonian paediatric intensive care unit. Journal of Hospital Infection, 86(2), 95 - 99.

 

Pavelkovich, Anastasia; Balode, Arta; Edquist, Petra; Egorova, Svetlana; Ivanova, Marina; Kaftyreva, Lidia; Konovalenko, Irina; Kõljalg, Siiri; Lillo, Jana; Lipskaya, Lidia; Miciuleviciene, Jolanta; Pai, Kristiine; Parv, Kristel; Pärna, Katri; Rööp, Tiiu; Sepp, Epp; Štšepetova, Jelena; Naaber, Paul (2014). Detection of Carbapenemase-Producing Enterobacteriaceae in the Baltic Countries and St. Petersburg Area. BioMed Research International, 2014, Article 548960

 

Sepp E, Kolk H, Lõivukene K, Mikelsaar M. Higher blood glucose level associated with body mass index and gut microbiota in elderly people. Microb Ecol Health Dis. 2014 Jun 3;25.

 

Talja I, Kubo AL, Veijola R, Knip M, Simell O, Ilonen J, Vähä-Mäkilä M, Sepp E, Mikelsaar M, Utt M, Uibo R. Antibodies to Lactobacilli and Bifidobacteria in young children with different propensity to develop islet autoimmunity. J Immunol Res. 2014;2014:325938.

 

Türk S, Mazzoli S, Stšepetova J, Kuznetsova J, Mändar R. Coryneform bacteria in human semen: inter-assay variability in species composition detection and biofilm production ability. Microb Ecol Health Dis. 2014 Feb 14;25.

 

Vengerfeldt V, Spilka K, Saag M, Preem JK, Oopkaup K, Truu J, Mändar R. Highly Diverse Microbiota in Dental Root Canals in Cases of Apical Periodontitis (Data of Illumina Sequencing). J Endod. 2014 Sep 13. pii: S0099-2399(14)00574-3.

 

 

2013

Ausmees K, Korrovits P, Timberg G, Punab M, Mändar R. (2013). Semen quality and associated reproductive indicators in middle-aged males: the role ofnon-malignant prostate conditions and genital tract inflammation. World J Urol. 2013 Dec;31(6):1411-25.

 

Brilene T, Soeorg H, Kiis M, Sepp E, Kõljalg S, Lõivukene K, Jürna-Ellam M,Kalinina J, Stšepetova J, Metsvaht T, Lutsar I. (2013)  In vitro synergy of oxacillin andgentamicin against coagulase-negative staphylococci from blood cultures ofneonates with late-onset sepsis. APMIS. Sep;121(9):859-64.

 

Lill, M.; Kõks, S.; Soomets, U.; Schalkwyk, LC.; Fernandes, C.; Lutsar, I.; Taba, P. (2013). Peripheral blood RNA gene expression profiling in patients with bacterial meningitis. Frontiers in Neuroscience, 7, 33.

 

Mändar, Reet (2013). Microbiota of male genital tract: Impact on the health of man and his partner. Pharmacological Research, 69(1), 32 - 41.

 

Punab, Margus; Kullisaar, Tiiu; Mändar, Reet (2013). Male Infertility Workup Needs Additional Testing of Expressed Prostatic Secretion and/or Post-Massage Urine . PLoS ONE, 8(12), e82776

 

Sepp, E.; Lõivukene, K.; Julge, K.; Voor, T.; Mikelsaar, M. (2013). The association of gut microbiota with body weight and body mass index in preschool children of Estonia. Microbial Ecology in Health and Disease, 24, 19231

 

Sharafedtinov KK, Plotnikova OA, Alexeeva RI, Sentsova TB, Songisepp E, Stsepetova J, Smidt I, Mikelsaar M. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients--a randomized double-blind placebo-controlled pilot study. Nutr J. 2013 Oct 12;12:138.

 

Soeorg H, Huik K, Parm U, Ilmoja ML, Metelskaja N, Metsvaht T, Lutsar I. (2013). Genetic relatedness of coagulase-negative Staphylococci from gastrointestinal tract and blood of preterm neonates with late-onset sepsis. Pediatr Infect Dis J. Apr;32(4):389-93.

 

Егорова, СА; Кафтыреща, ЛА; Липская, ЛВ; Коноваленко, ИБ; Пясетская, МФ; Курчикова, ТС; Ведерникова, НБ; Морозова, ОТ; Смирнова, МБ; Попенко, ЛН; Любушкина, МИ; Савочкина, ЮА; Макарова, МА; Сужаева, ЛВ; Останкова, ЮВ; Иванова, МН; Павелкович, АМ; Наабер, П; Сепп, Э; Кыльялг, С; Мицюлявичене, И; Балоде, А. (2013). Штаммы энтеробактерий, продуцирующие бета-лактамазы пасширенного спектра и металло-В-лактамазу НДМ-1, выделенные в стационарах в странах Балтийского региона. Инфекция и иммунитет, 3(1), 29 - 36.

 

 

2012

 

Adamson, V.; Mitt, P.; Pisarev, H.; Metsvaht, T.; Telling, K.; Naaber, P.; Maimets, M. (2012). Prolonged outbreak of Serratia marcescens in Tartu University hospital: a case-control study. BMC Infectious Diseases, 12(1), 281

 

Songisepp, E.; Hütt, P.; Rätsep, M.; Shkut, E.; Kõljalg, S.; Truusalu, K.; Stsepetova, J.; Smidt, I.; Kolk, H.; Zagura, M.; Mikelsaar, M. (2012). Safety of probiotic cheese containing Lactobacillus plantarum Tensia according to a variety of health indices in different age groups. Journal of Dairy Science, 95(10), 5495 - 5509.

 

Mikelsaar, Marika; Hütt, Pirje; Stsepetova, Jelena; Smidt, Imbi; Shkut, Elena; Rätsep, Merle; Zilmer, Mihkel; Songisepp, Epp (2012). Probiotic Heart cheese "Harmony" comprising L. plantarum Tensia influences blood pressure and metabolic health indices (in Russian). Voprossõ pitanija, 81(3), 74 - 81.  Микельсаар, M; Хютт, П; Щепетова, E; Смидт, И.; Шкут, Е.; Рятсеп, М.; Зильмер, М.; Сонгисэпп, Е. (2012). Влияние пробиотического Сердечного сыра «Harmony», содержащего бактерии L. plantarumTENSIA® DSM 21380, на артериальное давлениеи метаболические показатели здоровья. Вопросы питания, 81(3), 74 - 81.

 

 

2011

 

Metsvaht T, Ilmoja ML, Parm U, Merila M, Maipuu L, Müürsepp P, Julge K, Sepp E, Lutsar I. Ampicillin versus penicillin in the empiric therapy of ELBW neonates at risk of early onset sepsis. Pediatr Int. 2011 Sep 5. doi: 10.1111/j.1442-200X.2011.03468.x. [Epub ahead of print] PubMed PMID: 21895866.

 

Parm Ü, Metsvaht T, Sepp E, Ilmoja ML, Pisarev H, Pauskar M, Lutsar I. Mucosal surveillance cultures in predicting Gram-negative late-onset sepsis in neonatal intensive care units. J Hosp Infect. 2011 Aug;78(4):327-32. PubMed PMID: 21684633.

 

Parm U, Metsvaht T, Sepp E, Ilmoja ML, Pisarev H, Pauskar M, Lutsar I. Risk factors associated with gut and nasopharyngeal colonization by common Gram-negative species and yeasts in neonatal intensive care units patients. Early Hum Dev. 2011 Jun;87(6):391-9. Epub 2011 Mar 21. PubMed PMID: 21419584.

 

Lutsar I, Trafojer UM, Heath PT, Metsvaht T, Standing J, Esposito S, Meiffredy de Cabre V, Oeser C, Aboulker JP. Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial. Trials. 2011 Sep 30;12(1):215. [Epub ahead of print] PubMed PMID: 21958494.

 

Hütt P, Kõll P, Stsepetova J, Alvarez B, Mändar R, Krogh-Andersen K, Marcotte H, Hammarström L, Mikelsaar M. (2011). Safety and persistence of orally administered human Lactobacillus sp. strains in healthy adults. Beneficial Microbes 2: 79-90.

 

Borovkova N, Korrovits P, Ausmees K, Türk S, Jõers K, Punab M, Mändar R. (2011). Influence of sexual intercourse on genital tract microbiota in infertile couples. Anaerobe, in press.

 

Sepp E, Stšepetova J, Smidt I, Rätsep M, Kõljalg S, Lõivukene K, Mändar R, Jaanimäe L, Löhr IH, Natås OB, Naaber P. (2011). Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea. Anaerobe, in press.

 

Štšepetova, J.; Sepp, E.; Kolk, H.; Lõivukene, K.; Songisepp, E.; Mikelsaar, M. (2011). Diversity and metabolic impact of intestinal Lactobacillus sp. in healthy adults and the elderly. British Journal of Nutrition, 1 - 10.

 

Uibo, R.; Panarina, M.; Teesalu, K.; Talja, I.; Sepp, E.; Utt, M.; Mikelsaar, M.; Heilman, K.; Uibo, O.; Vorobjova, T. (2011). Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity? Cellular and Molecular Immunology, 8(2), 150 - 156.


Mikelsaar, M. (2011). Human microbial ecology: lactobacilli, probiotics, selective decontamination. Anaerobe, 1 - 5.

 

Kullisaar, T.; Shepetova, J.; Zilmer, K.; Songisepp, E.; Rehema, A.; Mikelsaar, M.; Zilmer, M. (2011). An antioxidant probiotic reduces postprandial lipemia and oxidative stress. Central European Journal of Biology, 6, 32 - 40.

 

Metsvaht, T.; Ilmoja, ML.; Parm, U.; Merila, M.; Maipuu, L.; Müürsepp, P.; Julge, K.; Sepp, E.; Lutsar, I. (2011). Ampicillin versus penicillin in the empiric therapy of ELBW neonates at risk of early onset sepsis. Pediatrics International, xx(xx), x - x. [ilmumas]

 

Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Jaanimäe, Liis; Löhr, Iren; Natås, Olav; Truusalu, Kai; Sepp, Epp (2011). Quantification of Clostridium difficile in Antibiotic-Associated Diarrhea Patients. Journal of Clinical Microbiology, xx [ilmumas]

 

 

2010

 

Kõll P, Mändar R, Smidt I, Hütt P, Truusalu K, Mikelsaar RH, Shchepetova J, Krogh-Andersen K, Marcotte H, Hammarström L, Mikelsaar M. Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probiotics. Curr Microbiol. 2010 Dec;61(6):560-6. Epub 2010 May 5. PubMed PMID: 20443005.

 

Kullisaar T, Songisepp E, Aunapuu M, Kilk K, Arend A, Mikelsaar M, Rehema A, Zilmer M. Complete glutathione system in probiotic Lactobacillus fermentum ME-3. Prikl Biokhim Mikrobiol. 2010 Sep-Oct;46(5):527-31. PubMed PMID: 21058502.

 

Lutsar I, Metsvaht T. Understanding pharmacokinetics/pharmacodynamics in managing neonatal sepsis. Curr Opin Infect Dis. 2010 Jun;23(3):201-7. Review. PubMed PMID: 20179595.

 

Metsvaht T, Ilmoja ML, Parm U, Maipuu L, Merila M, Lutsar I. Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis. Acta Paediatr. 2010 May;99(5):665-72. Epub 2010 Jan 20. PubMed PMID: 20096030.

 

Mikelsaar M, Stsepetova J, Hütt P, Kolk H, Sepp E, Lõivukene K, Zilmer K, Zilmer M. Intestinal Lactobacillus sp. is associated with some cellular and metabolic characteristics of blood in elderly people. Anaerobe. 2010 Jun;16(3):240-6. Epub 2010 Mar 17. PubMed PMID: 20223288.

 

Pähkla ER, Jõgi E, Nurk A, Pisarev H, Koppel T, Naaber P, Saag M, Lõivukene K. Periodontal disease in mothers indicates risk in their children. Int J Paediatr Dent. 2010 Jan;20(1):24-30. PubMed PMID: 20059590.

 

Parm U, Metsvaht T, Sepp E, Ilmoja ML, Pisarev H, Pauskar M, Lutsar I. Impact of empiric antibiotic regimen on bowel colonization in neonates with suspected early onset sepsis. Eur J Clin Microbiol Infect Dis. 2010 Jul;29(7):807-16. Epub  2010 May 6. PubMed PMID: 20446013.

 

Smidt, I.; Sepp, E.; Rätsep, M.; Kõljalg, S.; Lõivukene, K.; Löhr, I.; Natas, O.; Mändar, R.; Naaber, P. (2010). Quantitative evaluation of Clostridium difficile and intestinal lactobacilli in patients with associated diarrhoea. In: Clinical Microbiology and Infection: 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria 10-13 april 2010. , 2010, (2), S575.

 

Suitso, I.; Jõgi, E.; Talpsep, E.; Naaber, P.; Lõivukene, K.; Ots, M.-L.; Michelson, T.; Nurk, A. (2010). Protective effect by Bacillus smithii TBMI12 spores of Salmonella Enteritidis in mice. Beneficial Microbes, 37 - 42.

 

Truusalu K, Kullisaar T, Hütt P, Mahlapuu R, Aunapuu M, Arend A, Zilmer M, Mikelsaar RH, Mikelsaar M. Immunological, antioxidative, and morphological response in combined treatment of ofloxacin and Lactobacillus fermentum ME-3 probiotic in Salmonella Typhimurium murine model. APMIS. 2010 Nov;118(11):864-72. doi: 10.1111/j.1600-0463.2010.02672.x. Epub 2010 Sep 14. PubMed PMID: 20955459.

 

Walsh TJ, Driscoll T, Milligan PA, Wood ND, Schlamm H, Groll AH, Jafri H, Arrieta AC, Klein NJ, Lutsar I. Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children. Antimicrob Agents Chemother. 2010 Oct;54(10):4116-23. Epub 2010 Jul 26. PubMed PMID: 20660687; PubMed Central PMCID: PMC2944563.

 

 

2009

 

Metsvaht T., Pisarev H., Ilmoja M. L., Parm U., Maipuu L., Merila M., Muursepp P. & Lutsar I. (2009) Clinical parameters predicting failure of empirical antibacterial therapy in early onset neonatal sepsis, identified by classification and regression tree analysis. BMC Pediatr 9, 72.

 

Sepp E., Stsepetova J., Loivukene K., Truusalu K., Koljalg S., Naaber P. & Mikelsaar M. (2009) The occurrence of antimicrobial resistance and class 1 integrons among commensal Escherichia coli isolates from infants and elderly persons. Ann Clin Microbiol Antimicrob 8, 34.

 

Domeika M., Savicheva A., Sokolovskiy E., Frigo N., Brilene T., Hallen A., Unemo M., Ballard R. C. & Ward M. (2009) Guidelines for the laboratory diagnosis of Chlamydia trachomatis infections in East European countries. J Eur Acad Dermatol Venerol. 23:1353-1363.

 

Türk S, Punab M, Mändar R. Antimicrobial susceptibility patterns of coryneform bacteria isolated from semen. Open Infect Dis J, 2009; 3: 31-36.

 

Lutsar, I., I. Anca, M. Bakir, V. Usonis, R. Prymula, N. Salman, P. Grezesiowski, and M. Greenberg. 2008. Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005.  Eur J Pediatr. 2009 Apr;168(4):407-15.

 

Hütt P, Andreson H, Kullisaar T, Vihalemm T, Unt E, Kals J, Kampus P, Zilmer M, Mikelsaar M. Effects of a synbiotic product on blood antioxidative activity in subjects colonized with Helicobacter pylori. Lett Appl Microbiol. 2009 Jun;48(6):797-800.

 

Karlsson MO, Lutsar I, Milligan PA. Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies. Antimicrob Agents Chemother. 2009 Mar;53(3):935-44.

 

Kõljalg S, Truusalu K, Vainumäe I, Stsepetova J, Sepp E, Mikelsaar M. Persistence of Escherichia coli clones and phenotypic and genotypic antibiotic resistance in recurrent urinary tract infections in childhood. J Clin Microbiol. 2009 Jan;47(1):99-105.

 

Mikelsaar M, Zilmer M. Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic. Microb Ecol Health Dis. 2009 Mar 16. [Epub ahead of print] PubMed PMID: 19381356; PubMed Central PMCID: PMC2670518.

 

Prangli AL, Utt M, Talja I, Sepp E, Mikelsaar M, Rajasalu T, Uibo O, Tillmann V, Uibo R. Antigenic proteins of Lactobacillus acidophilus that are recognised by serum IgG antibodies in children with type 1 diabetes and coeliac disease. Pediatr Allergy Immunol. 2009 Jul 2.

 

 

2008


Koll, P., R. Mandar, H. Marcotte, E. Leibur, M. Mikelsaar, and L. Hammarstrom. 2008. Characterization of oral lactobacilli as potential probiotics for oral health. Oral Microbiol Immunol 23:139-47.

 

Meriste, S., J. M. Jacquet, P. Willems, and I. Lutsar. 2008. Immunologic response to Hib tetanus toxoid conjugated vaccine coadministered with DTPa either mixed or in two separate injections in toddlers not primed with Hib vaccine. Hum Vaccin 4:31-5.

 

Troke, P., K. Aguirrebengoa, C. Arteaga, D. Ellis, C. H. Heath, I. Lutsar, M. Rovira, Q. Nguyen, M. Slavin, and S. C. Chen. 2008. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 52:1743-50.

 

Truusalu, K., R. H. Mikelsaar, P. Naaber, T. Karki, T. Kullisaar, M. Zilmer, and M. Mikelsaar. 2008. Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiol 8:132.

 

 

2007

 

Andreson, H., T. Sillakivi, M. Peetsalu, A. Peetsalu, and M. Mikelsaar. 2007. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation. Scand J Gastroenterol 42:324-9.

 

Olak, J., R. Mandar, S. Karjalainen, E. Soderling, and M. Saag. 2007. Dental health and oral mutans streptococci in 2-4-year-old Estonian children. Int J Paediatr Dent 17:92-7.

 

Metsvaht, T., K. Oselin, M. L. Ilmoja, K. Anier, and I. Lutsar. 2007. Pharmacokinetics of penicillin g in very-low-birth-weight neonates. Antimicrob Agents Chemother 51:1995-2000.

 

Stsepetova, J., E. Sepp, K. Julge, E. Vaughan, M. Mikelsaar, and W. M. de Vos. 2007. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 51:260-9.

 

Turk, S., P. Korrovits, M. Punab, and R. Mandar. 2007. Coryneform bacteria in semen of chronic prostatitis patients. Int J Androl 30:123-8.

 

Tamm, E., P. Naaber, M. Maimets, M. Oona, S. Koljalg, and I. Lutsar. 2007. Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999-2003. Clin Microbiol Infect 13:824-6.

 

 

2006

 

Altraja A, Naaber P, Tamm E, Meriste S, Kullamaa A, Leesik H. Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia. J Chemother. 2006 Dec;18(6):603-9.

 

Andreson, H., Sillakivi, T., Peetsalu, M., Peetsalu, A., Mikelsaar, M. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation. Scand. J. Gastroenterol., 2006, 41.

 

Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol. 2006 Jun;100(6):1324-32.

 

Korrovits, P., Punab, M., Türk. S., Mändar, R. Seminal microflora in asymptomatic inflamatory (NIH IV category) prostatitis. Eur. Urology, 2006.

 

Lõivukene K, Kermes K, Sepp E, Adamson V, Mitt P, Jurna M, Magi H, Kallandi U, Otter K, Naaber P. The comparison of susceptibility patterns of Gram-negative invasive and non-invasive pathogens in Estonian hospitals. Antonie Van Leeuwenhoek. 2006 Apr-May;89(3-4):367-71.

 

Lõivukene K, Sepp E, Adamson V, Mitt P, Kallandi U, Otter K, Naaber P. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data. Scand J Infect Dis. 2006;38(11-12):1001-8.

 

Lõivukene, K., Kermes, K., Sepp, E., Adamson, V., Mitt, P., Kallandi, U., Otter, K., Naaber, P., European Antimicrobial resistance Surveillance System, Estonian Study Group. Surveillance of antimicrobial resistance of invasive pathogens: the Estonian experience. Euro Surveill. 2006 Feb;11(2):47-9.

 

Marcotte H, Koll-Klais P, Hultberg A, Zhao Y, Gmur R, Mandar R, Mikelsaar M, Hammarstrom L. Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus. J Appl Microbiol. 2006 Feb;100(2):256-63.

 

Pähkla ER, Koppel T, Naaber P, Saag M, Loivukene K. The efficacy of non-surgical and systemic antibiotic treatment on smoking and non-smoking periodontitis patients. Stomatologija. 2006;8(4):116-21.

 

Vendt, N., Grünberg, H., Tuure, T., Malminiemi, O., Wuolijoki, E., Tillmann, V., Sepp, E., Korpela, R. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J. Human Nutr. Diet., 2006, 19, 51.

 

 

2005

 

Karjagin, J., Pähkla, R., Karki, T., Starkopf, J. Distribution of metronidazole in muscle tissue of patients with spetic shock and its efficacy against Bacteroides fragilis in vitro. J. Antimicr. Chemother., 2005, 55, 341-346.

 

Kasenõmm, P., Piirsoo, A., Kull, M., Kull, M. Jr, Mikelsaar, M. Selection of indicators for tonsillectomy in adults with recurrent tonsillitis. BMC Ear, Nose and Throat Disorders 2005, 5:7

 

Kõll-Klais P, Mändar R, Leibur E, Marcotte H, Hammarström L, Mikelsaar M. (2005). Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol, 2005, 20, 354-361.

 

Kõll-Klais, P., Mändar, R., Leibur, E., Mikelsaar, M. Oral microbial ecology in chronic periodontitis and periodontal health. Micr. Ecol. Health Dis., 2005, 17, 146-155.

 

Mändar R, Raukas E, Türk S, Korrovits P, Punab M. (2005). Mycoplasmas in semen of chronic prostatitis patients. Scand J Urol Nephrol 39: 479-482.

 

Sepp E., Julge K., Mikelsaar M., Björksten B. Intestinal microbiota and immunoglobulin E response in 5-year-old Estonian children. Clin.Exper. Allergy, 35, 1141-1146.

 

Songisepp E., Kals J., Kullisaar T., Hütt P., Mändar R., Zilmer M., Mikelsaar M. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutrition Journal, 2005, 4:22.

 

Usonis V, Meriste S, Bakasenas V, Lutsar I, Collard F, Stoffel M, Tornieporth N. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months. Vaccine. 2005; 23: 2602-6

 

 

2004

 

Naaber, P., Smidt, I., Štšepetova, J., Brilene, T., Annuk, H., Mikelsaar, M. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J. Med. Microbiol., 2004, 53, 551-554.

 

Naaber, P., Mikelsaar, M. Interactions between lactobacilli and antibiotic-associated diarrhea. In: Advances in Applied Microbiology. Eds. A.I. Laskin, J.W. Bennett, G.M. Gadd. Volume 54. Elsevier Inc., 2004, 231-260.

 

Songisepp, E., Kullisaar, T., Hütt, P., Elias, P., Brilene, T., Zilmer, M., Mikelsaar, M. A new probiotic cheese with antioxidative and antimicrobial activity. J. Dairy Sci., 2004, 87, 2017-2023.

 

Truusalu K, Naaber P, Kullisaar T, Tamm H, Mikelsaar R-H, Zilmer K, Rehema A, Zilmer M, Mikelsaar M. The influence of antibacterial and antioxidative probiotic lactobacilli on gut mucosa in a mouse model of Salmonella infection. Microbial Ecology in Health and Disease 2004, 16:4, 180-187.

 

Kõll-Klais, P., Mändar, R., Leibur, E., Kjaeldgaard M. High levels of salivary lactobacilli in Estonian schoolchildren. Eur. J. Paed. Dent., 2004, 2, 107-109.

 

Maaroos, H.-I., Andreson, H., Lõivukene, K., Hütt, P., Kolk, H., Kull, I., Labotkin, K., Mikelsaar, M. The diagnostic value of endoscopy and Helicobacter pylori tests for peptic ulcer patients in late post-treatment setting. BMC Gastroenterology, 2004, ,4, 27.

 

 

2003

 

Annuk, H., Shchepetova, J., Kullisaar, T., Songisepp, E., Zilmer, M., Mikelsaar, M. Characterization of intestinal lactobacilli as putative probiotic candidates. J. Appl. Microbiol., 2003, 94, 403-412.

 

Kullisaar, T., Songisepp, E., Mikelsaar, M., Zilmer, K., Vihalemm, T., Zilmer, M. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br. J. Nutr., 2003, 90, 449-456.

 

Lõivukene, K., Naaber, P. Antibiotic susceptibility of clinically relevant anaerobes in Estonia from 1999 to 2001. Anaerobe, 2003, 9, 57-61.

 

Tapfer, H., Liigant, A., Simovart, H.E., Põldoja, E., Kokk, K., Naaber, P., Talvik, R. Dissemination of bacteria in multiple organs associated with apoptosis and macrophage activity in different stages of experimental sepsis. Scand. J. Surg., 2003, 92, 163-170.

 

Kermes K., Punab M., Lõivukene K., Mändar R.. Anaerobic seminal fluid microflora in chronic prostatitis/chronic pelvic pain syndrome patients. Anaerobe 2003, 9, 117-123.

 

Punab M., Lõivukene K., Kermes K., Mändar R. (2003). The limit of leukocytospermia from the microbiological viewpoint. Andrologia, 2003, 35, 271-278.

 

 

2002

 

Andreson H, Lõivukene K, Sillakivi T, Maaroos H-I, Ustav M, Peetsalu A, Mikelsaar M. Association of cagA and vacA genotypes of Helicobacter pylori with gastric diseases in Estonia. J. Clin. Microbiol., 2002, 40, 298-300.

 

Hynes SO, Broutet N, Eurohepygast Study Group, Wadström T, Mikelsaar M, O'Toole PW, Telford J, Engstrand L, Kamiya S, Mentis AF, Moran AP. Phenotypic variation of Helicobacter pylori isolates from geographically distinct regions detected by lectin typing. J. Clin. Microbiol., 2002, 40, 227-232.

 

Kolk H, Maaroos H-I, Kull I, Labotkin K, Lõivukene K, Mikelsaar M. Open access endoscopy in an epidemiological situation of high prevalence of Helicobacter pylori infection: applicability of the guidelines of the European Society for Primary Care Gastroenterology. Family Practice, 2002, 19, 3, 231-235.

 

Krüüner A, Pehme L, Ghebremichael S, Koivula T, Hoffner SE, Mikelsaar M. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Clin. Infect. Dis., 2002, 35, 146-155.

 

Kõljalg S, Naaber P, Mikelsaar M. Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. J. Hosp. Infect., 2002, 51, 106-113.

 

Kasenõmm P, Kull M, Mikelsaar M. Association between tonsillar core microflora and post-tonsillectomy bacteremia. Micr. Ecol. Health Dis., 2002, 14, 122-127.

 

Mikelsaar M, Annuk H, Stsepetova J, Mändar R, Sepp E, Björksten B. Intestinal lactobacilli of Estonian and Swedish children. Micr. Ecol. Health Dis., 2002, 14, 75-80.

 

Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, Kairane C, Kilk A. Two antioxidative lactobacilli strains as promising probiotics. Int. J. Food Microbiol., 2002, 72, 215-224.

 

Lõivukene K, Maaroos H-I, Kolk H, Kull I, Labotkin K, Mikelsaar M. Prevalence of antibiotic resistance of Helicobacter pylori isolates in Estonia during 1995-2000 in comparison to the consumption of antibiotics used in treatment regimens. Clin. Microbiol. Infect., 2002, 8, 598-603.

 

 

2001

 

Krüüner A, Danilovitsch M, Pehme L, Laisaar T, Hoffner SE, Katila ML. Tuberculosis as an occupational hazard for health care workers in Estonia. Int. J. Tuberc. Lung Dis., 2001, 2, 170-176.

 

Lockman S, Krüüner A, Binkin NJ, Levina K, Wang YC, Danilovitsch M, Hoffner SE, Tappero JW. Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis. Clin. Infect. Dis., 2001, 32, 373-380.

 

Karki T, Truusalu K, Vainumäe I, Mikelsaar M. Antibiotic susceptibility patterns of community- and hospital-acquired Staphylococcus aureus and Escherichia coli in Estonia. Scand. J. Infect. Dis., 2001, 33, 333-338.

 

Mändar R, Lõivukene K, Hütt P, Karki T, Mikelsaar M. Antibacterial susceptibility of intestinal lactobacilli of healthy children. Scand. J. Infect. Dis., 2001, 33, 344-349.

 

Annuk H, Hynes SO, Hirmo S, Mikelsaar M, Wadström T. Characterisation and differentiation of lactobacilli by lectin typing. J. Med. Microbiol., 2001, 50, 1-6.

 

Mändar R, Lõivukene K, Ehrenberg A, Smidt I, Raukas E, Kask V, Mikelsaar M. Amniotic fluid microflora in asymptomatic women at mid-gestation. Scand. J. Infect. Dis., 2001, 33, 60-62.

 

Sillakivi T, Aro H, Ustav M, Peetsalu M, Peetsalu A, Mikelsaar M. Diversity of Helicobacter pylori genotypes among Estonian and Russian patients with perforated peptic ulcer, living in South Estonia. FEMS Microbiol. Letters, 2001, 195, 29-33.

 

Naaber P, Tamm E, Pütsepp A, Kõljalg S, Maimets M. Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children. Clin. Microbiol. Infect., 2000, 12, 6, 675-686.

 

Sillakivi T, Peetsalu M, Mikelsaar M, Peetsalu A. An attempt at Helicobacter pylori eradication with intravenous clarithromycin in perforated peptic ulcer patients. Scand. J. Gastroenterol., 2001, 36, 1119-1120.

 

Krüüner A, Hoffner SE, Sillastu H, Danilovits M, Levina K, Svenson SB, Ghebremichael S, Koivula T, Källenius G. Spread of drug-resistant pulmonary tuberculosis in Estonia. J. Clin. Immunol., 2001, 39, 9, 3339-3345.

 

Björksten B, Sepp E, Julge K, Voor T, Mikelsaar M. The intestinal microflora during the first year of life and the development of allergy. J. Allergy Clin. Immunol. 2001, 108, 516-520

 

 

2000

 

Annuk H., Vainumäe I., Aimla K., Ausmees K., Kullisaar T., Kask S., Mikelsaar M. Antagonistic activity of lactobacilli against urinary Escherichia coli. Microecol. Therapy, 1999, 28, 169-175.

 

Mikelsaar M., Türi E., Türi M., Smidt I. Interaction of Lactobacillus fermentum and Escherichia coli in guinea pig testes model. Micr. Ecol. Therapy, 1999, 28, 319-326.

 

Naaber P., Smidt I., Tamme K., Liigant A., Tapfer H., Mikelsaar M., Talvik R. Translocation of indigenous microflora in an experimental model of sepsis. J. Med. Microbiol., 2000, 49, 431-439.

 

Lõivukene K., Kolk H., Maaroos H.-I., Kasenõmm P., Aro H., Ustav M., Mikelsaar M. Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia. Scand. J. Infect. Dis., 2000, 32, 59-62.

 

Sepp E., Naaber P., Voor T., Mikelsaar M., Björksten B. Development of intestinal microflora during the first month of life in Estonian and Swedish infants. Micr. Ecol. Health Dis., 2000, 12, 22-26.

 

Naaber P, Kõljalg S, Maimets M. Antibiotic Usage and Resistance Trends in Estonian University Hospitals. International Journal of Antimicrobial Agents; 2000; 16: 309-315

 

 

1999

 

Kõljalg, S., Sults, I., Raukas, E., Truu, J., Ustav, M., Mikelsaar, M. Distribution of Acinetobacter baumannii in a neurointensive care unit. - Scand. J. Infect. Dis., 1999, 31, 145-150.

 

Björksten, B. Naaber, P., Sepp, E., Mikelsaar, M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. - Clin. Exp. Allergy, 1999, 29, 342-346.

 

Annuk, H., Hirmo, S. Türi, E., Mikelsaar, M., Arak, E., Wadström, T. Effect on cell surface hydrophobicity and susceptibility of Helicobacter pylori to medicinal plant extracts - . FEMS Microbiology Letters, 1999, 172, 41-45.

 

Türi, E., Türi, M., Annuk, H., Arak, E. Action of aqueous extracts of bearberry and cowberry leaves and wild camomille and pineapple-weed flowers on Escherichia coli surface structures. - Pharmac. Biol., 1999, 37, 2, 127-133.

 

 

1998

 

Kaila, M., Isolauri, E., Sepp, E., Mikelsaar, M., Salminen, S. Fecal recovery of a human Lactobacillus strain (ATCC 53103) during dietary therapy of rotavirus diarrhea in infants. - Bioscience Microflora, 1998, 17, 2, 149-151

 

Krüüner, A., Sillastu, H., Danilovitsch, M., Levina, K., Svenson, S.B., Källenius, G., Hoffner, S.E.. Drug resistant tuberculosis in Estonia. - The Official Journal of the International Union Against Tuberculosis and Lung Disease "Tubercle and Lung Disease", 1998, 2, 2, 130-133.

 

Mäkinen, K.K., Olak, J., Russak, S., Saag, M., Seedre, T., Vasar, R., Vihalemm, T., Mikelsaar, M., Mäkinen, P.-L.. Polyol-combinant saliva stimulants: a 4-month pilot study in young adults. - Acta Odontologica Scandinavia, 1998, 56, 1-5.

 

Naaber, P., Mikelsaar, R.-H., Salminen, S., Mikelsaar, M.. Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection. - Journal of Medical Microbiology, 1998, 47, 591-598

 

 

1997

 

Naaber P, Klaus K, Sepp E, Björksten B, Mikelsaar M. Colonization of infants and hospitalized patients with Clostridium difficile and lactobacilli. Clinical Infectious Diseases 1997, 25, Suppl 2, 189-190.

 

Sepp E., Julge K., Vasar M., Naaber P., Björksten B., Mikelsaar M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatrica, 1997, 86, 956-961.

 

Türi M, Türi E, Kõljalg S, Mikelsaar M. Influence of aqueous extracts of medicinal plants on surface hyrophobicity of Escherichia coli strains of different origin. APMIS, 1997, 105, 956-962.

 

Naaber P., Maimets M., Mikelsaar M. Prevalence and properties of Clostridium difficile in hospitalized patients of Estonia. - Reviews in Medical Microbiology, Chapman & Hall, 1997, 8, Suppl 1, 60-61

 

Oona M, Rägo T, Maaroos H-I, Mikelsaar M, Lõivukene K, Salminen S, Korhonen H. Helicobacter pylori in children with abdominal complaints: has immune bovine colostrum some influence on gastritis? Alpe Adria Microbiology Journal, 1997, 6, 49-57.

 

Ormisson A, Sepp E, Siigur U, Varendi H, Mikelsaar M. Impact of early life nutrition on growth and intestinal microflora composition in low-birth-weight infants. Scand. J. Nutrition, 1997, 41, 71-74

 

 

1996

 

Kõljalg S., Vuopio-Varkila J., Mikelsaar M., Wadström T. Cell surface properties of Acinetobacter baumannii. - APMIS, 1996, 104, 659-665.

 

Mikelsaar M., Mändar R., Maaroos H.-I., Päär S., Rägo T., Kisand K., Aleljung P., Wadström T. Helicobacter pylori gastritis in children: clinical, bacteriological, and morphological study. - Microecology and Therapy, 1996, 22, 44-53

 

Mändar R., Mikelsaar M. Transmission of mother's microflora to the newborn at birth. - Biology of the Neonate, 1996, 69, 30-35

 

Naaber P., Lehto E., Salminen S., Mikelsaar M. Inhibition of adhesion of Clostridium difficile to Caco-2 cells. - FEMS Immunology and Medical Microbiology, 1996, 14, 205-209.

 

Mikelsaar M., Sepp E., Mändar R., Ormisson A. Criteria for evaluation of the faecal microflora. - Microecology and Therapy, 1995, 23, 149-150

 

Mändar R., Mikelsaar M. Vaginal microflora during pregnancy. - Alpe Adria Microbiology Journal, 1996, 5, 1, 41-50

 

Naaber P., Mikelsaar M. Antibiotic-compromised murine model of Clostridium difficile infection. - Microecology and Therapy, 1995, 25, 201-205

 

Sepp E., Tamm E., Torm S., Lutsar I., Mikelsaar M., Salminen S. Impact of a lactobacillus probiotic on the faecal microflora in children with shigellosis. - Microecology and Therapy, 1995, 23, 74-80.

 

 

1995

 

Karki, T., Lenzner, H., Lenzner, A. Quantitative composition of the human lactoflora and methods for its examination. Microecology and Therapy. Herborn-Dill, Germany, 1995, 21, 157-162.

 

Türi, M., Sepp, E., Mikelsaar, M. Putative virulence markers for Escherichia coli strains of different origin. Alpe Adria Microbiology Journal, Milano, 1995, 4, 4, 253-263. Ó Excerpta Medica EMBASE.


Mändar R, Saag H, Peil P, Mikelsaar M. Bacterial vaginosis during pregnancy. Microecology and Therapy, 1995; 23: 24-31.




PAPERS IN ESTONIAN

 

Türk, S.; Kermes, K.; Lõivukene, K.; Raukas, E.; Korrovits, P.; Punab, M.; Mändar, R. (2010). Sperma mikrofloora kroonilise prostatiidi korral. Eesti Arst, 89(2), 83 - 94.

 

Kasenõmm, P., Piirsoo, A., Kull, M. jn., Kull, M., Mikelsaar, M. (2005). Kroonilise tonsilliidi patogeneesi uuringud kui alus tonsillektoomia objektiivsete kriteeriumite leidmiseks. Eesti Arst, 84 (8), 531-541.

 

Kõll-Klais, P.; Mändar, R.; Mikelsaar, M.; Leibur, E. (2003). Suuõõne mikroobiökoloogia kroonilise parodontiidi puhul. Eesti Arst, 82(11): 759 -767.

 

Sepp E, Kõljalg S, Truusalu K, Štšepetova L, Metsvaht T, Sau L, Jürna M, Mägi H, Allik M, Mikelsaaar M. (2003). Staphylococcus epidermidis ja Klebsiella pneumoniae - võimalikud hospitaalinfektsioonide tekitajad Eesti lasteintensiivarvi osakondades. Eesti Arst 82(4): 239-248.

 

Järv H, Naaber P, Kaur S, Eisen M, Silm H. Varbaküünte seenhaigus Eestis ? võrdlus Euroopa maadega. Eesti Arst 2002; 81: 338-342

 

Krüüner A. Mycobacterium tuberculosis'e levik, mikrobioloogilise diagnostika võimalused ja ravimiresistentsus Eestis. Eesti Arst, 2001, 3, 131-139.

 

Songisepp E., Mikelsaar M. Rukkileiva juuretise kvaliteeti kindlustavad leivajuuretise piimhappebakterid. Põllumajandus, 2000, 4,5, 5-7.

 

Lõivukene K., Kolk H., Maaroos H.-I., Mikelsaar M. Helicobacter pylori tüvede metronidasool- ja klaritromütsiintundlikkus Eesti patsientide seas. Eesti Arst, 2000, 8, 453-459.

 

Kõljalg S., Karki T., Olsson-Liljequist B. Metsitsilliin-resistentse Staphylococcus aureus'e esinemissagedus Eestis. Eesti Arst, 2000, 8, 466-470.

 

Mikelsaar M. Esilekerkivad infektsioonid. Eesti Arst, 2000, 8, 471-480.

 

Kasenõmm, P. Krooniline retsidiveeruv tonsilliit. Eesti Arst, 2000, 8, 481-485.

 

Mändar R. Antibakteriaalsete preparaatide mõju normaalsele mikrofloorale. Eesti Arst, 2000, 8, 486-491.

 

Karki T. Antibiootikumid ja antibiootikumresistentsus. Eesti Arst, 2000, 8, 492-498

 

Annuk H., Raukas M., Türi E., Türi M., Arak E. Leesikalehtede (Uvae ursi folium) vesitõmmiste toime Escherichia coli agregatiivsele aktiivsusele I. - Eesti Rohuteadlane, Tartu , 1997, 3, 3-5.

 

Annuk H., Raukas M., Türi E., Türi M., Arak E. Leesikalehtede (Uvae ursi folium) vesitõmmiste toime Escherichia coli agregatiivsele aktiivsusele II. Eesti Rohuteadlane, 1997, 4, 3-5.

 

Sepp E., Lõivukene K., Naaber P., Kermes K., Julge K., Vasar M., Björksten B., Mikelsaar M. Tervete ja allergiliste laste mikrofloora erinevused. Eesti Rohuteadlane, 1997, lisa, 62-63.

 

Sepp E., Metsvaht T. Vastsündinute bakterieemiate struktuur ja laboratoorne diagnoosimine Tartu Lastekliiniku intensiivraviosakonna andmeil.Eesti Arst, 1997, 6, 513-519.

 

Karki T., Vares P., Kõljalg S., Kirm A. Elektrokeemiliselt töödeldud vesilahuste bakteritsiidsest toimest in vitro. - Eesti Rohuteadlane, Tartu , 1997, lisa, 15-17.

 

Krüüner A., Danilovits M., Türi E. Ravimiresistentsete Mycobacterium tuberculosis'e tüvede osatähtsusest tuberkuloosi etioloogias Eestis. - Eesti Rohuteadlane, Tartu , 1997, lisa, 23-24.

 

Kõljalg S., Sults I., Raukas E., Mikelsaar M. Acinetobacter baumannii persisteerimine neurointensiivravi osakonnas. - Eesti Rohuteadlane, Tartu, 1997, lisa, 26-27.

 

Mikelsaar M., Karki T., Kirsberg E., Kõljalg S., Kermes K., Mägi H., Ivanova M., Rauk S., Timmas T., Jõks U. Uroinfektsioonidega Eesti patsientide Escherichia coli tüvede tundlikkus antibiootikumidele. - Eesti Rohuteadlane, Tartu , 1997, lisa, 35-36.

 

Mändar R., Lõivukene K., Türi M., Mikelsaar M. Eesti ja Rootsi lastelt isoleeritud laktobatsillitüvede tundlikkus antibiootikumide suhtes. - Eesti Rohuteadlane, Tartu, 1997, lisa, 37-38.

 

Mikelsaar M. Hospitaalinfektsioon tänapäeval. Eesti Arst, 1996, 3, 237-245

 

Karki T., Lenzner H., Lenzner A. Lactobacillus casei toime seedekulgla laktofloorasse. Eesti Arst, 1996, 1, 30-34.

 

Karki, T. Etüülalkohol ja inimese seedekulgla laktofloora. Eesti Arst, Tallinn, 1995, 5, 390-393.

 

Naaber, P. Clostridium difficile põhjustatud diarröa. Mikrobioloogilise diagnoosimise esmane kogemus Tartus. Eesti Arst. Tallinn, 1995, 1, 11-15.

 

Reinaste, R., Türi, M. Bensalkooniumkloriidsalvide antimikroobne aktiivsus. Eesti Rohuteadlane, Tartu, 1995, VI, 4, 147-149,

 

Türi, E., Türi, M. Ravimtaimede toimemehhanismist Escherichia coli suhtes. Eesti Rohuteadlane, Tartu, 1995, VI, 4, 149-151.

 

Mikelsaar, M. Kas inimkond vabaneb kunagi nakkushaigustest? Akadeemia. Tartu, 1995, 7 aastakäik, 1693-1711.

© 2013-2016 by University of Tartu, Estonia.
Version: 11. October, 2016.